Increased Sirtuin 6 Activity in Tumor Cells Can Prompt CD4-Positive T-Cell Differentiation Into Regulatory T Cells and Impede Immune Surveillance in the Microenvironment
World Journal of Oncology · 2025-04 · 16 (2) · 182-199
DOI: 10.14740/wjon2547 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Oncology, 2025-04. Verfasst von Nan Yang Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China.
- Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China.
- These authors contributed equally to this study.
Zitieren
APA
Zhang, N. Y., Liu, W. Y., Fang, K. H., & Chang, X. T. (2025). Increased Sirtuin 6 Activity in Tumor Cells Can Prompt CD4-Positive T-Cell Differentiation Into Regulatory T Cells and Impede Immune Surveillance in the Microenvironment. World Journal of Oncology, 16(2), 182-199. https://doi.org/10.14740/wjon2547
Vancouver
Zhang NY, Liu WY, Fang KH, Chang XT. Increased Sirtuin 6 Activity in Tumor Cells Can Prompt CD4-Positive T-Cell Differentiation Into Regulatory T Cells and Impede Immune Surveillance in the Microenvironment. World Journal of Oncology. 2025;16(2):182-199. doi:10.14740/wjon2547
BibTeX
@article{Zhang2025,
author = {Zhang, Nan Yang and Liu, Wen Yuan and Fang, Ke Hua and Chang, Xiao Tian},
title = {Increased Sirtuin 6 Activity in Tumor Cells Can Prompt CD4-Positive T-Cell Differentiation Into Regulatory T Cells and Impede Immune Surveillance in the Microenvironment},
journal = {World Journal of Oncology},
year = {2025},
volume = {16},
number = {2},
pages = {182--199},
doi = {10.14740/wjon2547}
}
EUVIMED